Gene · 714
C1QC: complement C1q C chain
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. C1QC: complement C1q C chain. Genes, record 714. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/714
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P02747 | Complement C1q subcomponent subunit C | 245 | 11 | Ensembl, GeneID, HGNC |
Source UniProt
Patents162
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705273 A2 | 2026-03-11 | 199 | P02747 | Espacenet |
| JP 2026028257 A | 2026-02-19 | 3 | P02747 | Espacenet |
| US 12534522 B2 | 2026-01-27 | 3 | P02747 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41966 | P02747 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41967 | P02747 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41968 | P02747 | Espacenet |
| EP 4670793 A1 | 2025-12-31 | 14 | P02747 | Espacenet |
| WO 2025262255 A1 | 2025-12-26 | 14 | P02747 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9495 | P02747 | Espacenet |
| WO 2025229160 A1 | 2025-11-06 | 21 | P02747 | Espacenet |
1 to 10 of 162
See all 162 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | C1QC papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 3 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 2 | 2025 |
1 to 10 of 1,173Source NIH's project files
See all 1,173 nih grantsPapers1,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating C1QC in cancer: analytical platforms, evidence gaps, and prospects for clinical chemistry translation. | Clin Chim Acta | 2027 | 42336257 | PubTator, text mining | PubMed |
| Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study. | Pharmgenomics Pers Med | 2026 | 42724811 | PubTator, text mining | PubMed |
| Complement Activation Linked to Type II Interferon Signaling in Still Disease. | Arthritis Rheumatol | 2026 | 42640011 | PubTator, text mining | PubMed |
| Spatially organized macrophage-T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics. | Front Immunol | 2026 | 42529136 | PubTator, text mining | PubMed |
| Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma. | Front Immunol | 2026 | 42500655 | PubTator, text mining | PubMed |
An interpretable multi-task whole-slide histopathology AI model for non-small cell lung cancer: Cross-cohort generalisation, spatial attention-transcriptomic integration, and molecular-immune profiling. | Clin Transl Med | 2026 | 42494157 | PubTator, text mining | PubMed |
| Spatial multi-omics identifies early synaptic pruning and context-specific dopaminergic vulnerability in synucleinopathies. | Nat Commun | 2026 | 42481480 | PubTator, text mining | PubMed |
| Genomic landscape of rare variants in a Chinese autism cohort and discovery of novel risk genes. | Mol Psychiatry | 2026 | 42463903 | PubTator, text mining | PubMed |
| Safety evaluation of repeated administration of umbilical cord mesenchymal stem cell-derived exosomes. | Stem Cell Res Ther | 2026 | 42421160 | PubTator, text mining | PubMed |
| Exploring shared biomarkers and their mechanisms in thyroid cancer and systemic lupus erythematosus via bioinformatics analysis. | Discov Oncol | 2026 | 42348043 | PubTator, text mining | PubMed |
1 to 10 of 1,427
See all 1,427 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/714
GET https://conductscience.org/api/genes/v1/714/patents?page=2